+157.2%
MRNA vs UL
-4.2%
+161.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | UL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.6% | +4.7% | +4.8% |
| 7D | -1.1% | -3.4% | +2.3% | +2.1% |
| 30D | +126.1% | +0.5% | +125.6% | +127.9% |
| 3M | +190.0% | +7.2% | +182.8% | +193.4% |
| 6M | +157.2% | -3.1% | +160.3% | +167.5% |
| All | +157.2% | -4.2% | +161.4% | +167.5% |
Cumulative growth
Daily Returns
Daily percentage return beside UL.
Daily Out/Under-Performance
Portfolio return minus UL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded UL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling